Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse - PubMed (original) (raw)
- PMID: 6865333
Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse
H Koen et al. Lab Invest. 1983 Jul.
Abstract
Hepatocellular foci, considered possible precursors of trabecular hepatocellular carcinomas, were induced after 10 weeks by injecting male B6C3 F1 mice with diethylnitrosamine, 5 mg/kg, when they were 15 days old. The locations of 41 of the foci with diameters between 80 and 112 microns were determined in serial sections of blocks of liver from five mice. The average distance between centers of foci and closest hepatic vein branches (143 microns) was 40% less than that between randomly selected points and veins (243 microns). The centrilobular distribution of the foci might have facilitated the infiltration of hepatic vein branches, which was a prominent feature in animals killed after 20 weeks. This is the first stereologic study documenting the nonrandom distribution of neoplastic or preneoplastic foci in the rodent liver.
Similar articles
- Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S, Pugh TD, Koen H, He YZ. Goldfarb S, et al. Environ Health Perspect. 1983 Apr;50:149-61. doi: 10.1289/ehp.8350149. Environ Health Perspect. 1983. PMID: 6873010 Free PMC article. - Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
Vesselinovitch SD, Mihailovich N. Vesselinovitch SD, et al. Cancer Res. 1983 Sep;43(9):4253-9. Cancer Res. 1983. PMID: 6871863 - Altered hepatic foci: their role in murine hepatocarcinogenesis.
Pitot HC. Pitot HC. Annu Rev Pharmacol Toxicol. 1990;30:465-500. doi: 10.1146/annurev.pa.30.040190.002341. Annu Rev Pharmacol Toxicol. 1990. PMID: 2188576 Review. No abstract available. - Trends in pathobiochemical studies of tumour development and progression.
Jeney A. Jeney A. Acta Morphol Hung. 1986;34(4):311-23. Acta Morphol Hung. 1986. PMID: 3118648 Review. No abstract available.
Cited by
- New and Old Key Players in Liver Cancer.
Cuesta ÁM, Palao N, Bragado P, Gutierrez-Uzquiza A, Herrera B, Sánchez A, Porras A. Cuesta ÁM, et al. Int J Mol Sci. 2023 Dec 5;24(24):17152. doi: 10.3390/ijms242417152. Int J Mol Sci. 2023. PMID: 38138981 Free PMC article. Review. - Genetically Engineered Mouse Models for Liver Cancer.
Cho K, Ro SW, Seo SH, Jeon Y, Moon H, Kim DY, Kim SU. Cho K, et al. Cancers (Basel). 2019 Dec 19;12(1):14. doi: 10.3390/cancers12010014. Cancers (Basel). 2019. PMID: 31861541 Free PMC article. Review. - Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology.
Vadalà M, Morales-Medina JC, Vallelunga A, Palmieri B, Laurino C, Iannitti T. Vadalà M, et al. Cancer Med. 2016 Nov;5(11):3128-3139. doi: 10.1002/cam4.861. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748048 Free PMC article. Review. - Proceedings of the 2013 Joint JSTP/NTP Satellite Symposium.
Elmore SA, Hoenerhoff M, Katsuta O, Kokoshima H, Maronpot R, Nagai H, Satoh H, Tanaka Y, Tochitani T, Tsuchiya S, Yoshizawa K. Elmore SA, et al. J Toxicol Pathol. 2013 Jun;26(2):231-57. doi: 10.1293/tox.26.231. Epub 2013 Jul 10. J Toxicol Pathol. 2013. PMID: 23914068 Free PMC article. - Assessment of hemodynamics in a rat model of liver cirrhosis with precancerous lesions using multislice spiral CT perfusion imaging.
Ma G, Bai R, Jiang H, Hao X, Ling Z, Li K. Ma G, et al. Biomed Res Int. 2013;2013:813174. doi: 10.1155/2013/813174. Epub 2013 Jun 20. Biomed Res Int. 2013. PMID: 23865067 Free PMC article.